AI MARKET SCANNING

$FATE

Fate Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP1.08%
MAX GAP RECORD8.78%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $FATE

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.1%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $FATE

AI REPORT
Jun 26

Overnight Gaps: A Comprehensive Guide to Trading and Risk Management

AnalysisThe financial markets are known for their dynamic nature, with one of the most notable phenomena being the…